Search research articles
Contact Us
Filters
Showing results (161-170 of 185) with videos related to
Page
of 19
Sort By:
Medrxiv : the Preprint Server for Health Sciences
|
August 8, 2025
Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutations
Matthew K Nguyen, Mark Jelinek, Arjun Singh, et al.
Journal for Immunotherapy of Cancer
|
April 19, 2024
Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease
Jason J Luke, Diwakar Davar, Robert H Andtbacka, et al.
The Lancet. Oncology
|
October 20, 2022
Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma (KEYNOTE-716): distant metastasis-free survival results of a multicentre, double-blind, randomised, phase 3 trial
Georgina V Long, Jason J Luke, Muhammad A Khattak, et al.
JCO Precision Oncology
|
April 13, 2023
Trametinib in Patients With <i>NF1-</i>, <i>GNAQ-</i>, or <i>GNA11</i>-Mutant Tumors: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols S1 and S2
Kari B Wisinski, Yael Flamand, Melissa A Wilson, et al.
The Oncologist
|
October 25, 2025
Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutations
Matthew K Nguyen, Mark Jelinek, Arjun Singh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 22, 2024
Nivolumab + Tacrolimus + Prednisone ± Ipilimumab for Kidney Transplant Recipients With Advanced Cutaneous Cancers
Kara M Schenk, Julie Stein Deutsch, Sunandana Chandra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 19, 2013
Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin
F Stephen Hodi, Christopher L Corless, Anita Giobbie-Hurder, et al.
Oral Oncology
|
November 10, 2025
Integrating artificial intelligence-driven digital pathology and genomics to establish patient-derived organoids as new approach methodologies for drug response in head and neck cancer
Rose Doerfler, Jie Chen, Carl Kim, et al.
Nature Communications
|
July 2, 2026
Years of life lost in patients with a false-negative diagnosis of primary melanoma. A prospective study of the German Central Malignant Melanoma Registry involving 9063 patients over 28 years
Claus Garbe, Ulrike Keim, Teresa Amaral, et al.
Biorxiv : the Preprint Server for Biology
|
July 16, 2025
Integrating Artificial Intelligence-Driven Digital Pathology and Genomics to Establish Patient-Derived Organoids as a Novel Alternative Model for Drug Response in Head and Neck Cancer
Rose Doerfler, Jie Chen, Carl Kim, et al.
Page
of 19
Search research articles
Search
Showing results (161-170 of 185) with videos related to
Sort By:
Page
of 19
Medrxiv : the Preprint Server for Health Sciences
|
August 8, 2025
Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutations
Matthew K Nguyen, Mark Jelinek, Arjun Singh, et al.
Journal for Immunotherapy of Cancer
|
April 19, 2024
Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease
Jason J Luke, Diwakar Davar, Robert H Andtbacka, et al.
The Lancet. Oncology
|
October 20, 2022
Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma (KEYNOTE-716): distant metastasis-free survival results of a multicentre, double-blind, randomised, phase 3 trial
Georgina V Long, Jason J Luke, Muhammad A Khattak, et al.
JCO Precision Oncology
|
April 13, 2023
Trametinib in Patients With <i>NF1-</i>, <i>GNAQ-</i>, or <i>GNA11</i>-Mutant Tumors: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols S1 and S2
Kari B Wisinski, Yael Flamand, Melissa A Wilson, et al.
The Oncologist
|
October 25, 2025
Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutations
Matthew K Nguyen, Mark Jelinek, Arjun Singh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 22, 2024
Nivolumab + Tacrolimus + Prednisone ± Ipilimumab for Kidney Transplant Recipients With Advanced Cutaneous Cancers
Kara M Schenk, Julie Stein Deutsch, Sunandana Chandra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 19, 2013
Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin
F Stephen Hodi, Christopher L Corless, Anita Giobbie-Hurder, et al.
Oral Oncology
|
November 10, 2025
Integrating artificial intelligence-driven digital pathology and genomics to establish patient-derived organoids as new approach methodologies for drug response in head and neck cancer
Rose Doerfler, Jie Chen, Carl Kim, et al.
Nature Communications
|
July 2, 2026
Years of life lost in patients with a false-negative diagnosis of primary melanoma. A prospective study of the German Central Malignant Melanoma Registry involving 9063 patients over 28 years
Claus Garbe, Ulrike Keim, Teresa Amaral, et al.
Biorxiv : the Preprint Server for Biology
|
July 16, 2025
Integrating Artificial Intelligence-Driven Digital Pathology and Genomics to Establish Patient-Derived Organoids as a Novel Alternative Model for Drug Response in Head and Neck Cancer
Rose Doerfler, Jie Chen, Carl Kim, et al.
Page
of 19